AMPLIFAI ONCOLOGY Trademark

Trademark Overview


On Friday, August 2, 2024, a trademark application was filed for AMPLIFAI ONCOLOGY with the United States Patent and Trademark Office. The USPTO has given the AMPLIFAI ONCOLOGY trademark a serial number of 98679923. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, March 25, 2025. This trademark is owned by Amplifai Oncology, Inc.. The AMPLIFAI ONCOLOGY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Software as a service (SaaS) services featuring software applications that enable radiotherapy healthcare practitioners to review and analyze medical images of tumors and soft tissue, and develop, review, share, collaborate, and obtain expert opinions and peer reviews on radiation therapy treatment plans; Software as a service (SaaS) services featuring software applications that render medical time sequence images as longitudinal views of the patient to monitor daily patient treatment setup, and track changes in patient anatomy and tumor volume; Software as a service (SaaS) services featuring software using artificial intelligence to predict and evaluate medical treatment parameters, and develop, adapt, and improve radiation therapy treatment plans.
amplifai oncology

General Information


Serial Number98679923
Word MarkAMPLIFAI ONCOLOGY
Filing DateFriday, August 2, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, March 25, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 25, 2025

Trademark Statements


NOT AVAILABLE"ONCOLOGY"
Translation of Words in MarkThe wording "AMPLIFAI" has no meaning in a foreign language.
Goods and ServicesSoftware as a service (SaaS) services featuring software applications that enable radiotherapy healthcare practitioners to review and analyze medical images of tumors and soft tissue, and develop, review, share, collaborate, and obtain expert opinions and peer reviews on radiation therapy treatment plans; Software as a service (SaaS) services featuring software applications that render medical time sequence images as longitudinal views of the patient to monitor daily patient treatment setup, and track changes in patient anatomy and tumor volume; Software as a service (SaaS) services featuring software using artificial intelligence to predict and evaluate medical treatment parameters, and develop, adapt, and improve radiation therapy treatment plans.

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 2, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAmplifai Oncology, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressReno, NV 89511

Party NameAmplifai Oncology, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressReno, NV 89511

Trademark Events


Event DateEvent Description
Friday, August 2, 2024NEW APPLICATION ENTERED
Thursday, January 16, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 10, 2025ASSIGNED TO EXAMINER
Thursday, February 13, 2025NON-FINAL ACTION E-MAILED
Thursday, February 13, 2025NON-FINAL ACTION WRITTEN
Monday, February 24, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 24, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 13, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 24, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 27, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 19, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 25, 2025PUBLISHED FOR OPPOSITION
Tuesday, March 25, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED